Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001493152-23-033277
Filing Date
2023-09-21
Accepted
2023-09-21 07:30:15
Documents
1
Period of Report
2023-09-20

Document Format Files

Seq Description Document Type Size
1 form6-ka.htm 6-K/A 15625
  Complete submission text file 0001493152-23-033277.txt   16629
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-36345 | Film No.: 231267743
SIC: 2834 Pharmaceutical Preparations